EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

18F-PI-2620 Tau PET is associated with cognitive and motor impairment in Lewy body disease

Joseph R Winer iD, Hillary Vossler, Christina B Young, Viktorija Smith, America Romero, Marian Shahid-Besanti, Carla Abdelnour, Edward N Wilson iD, David Anders, Aimara Pacheco Morales, Katrin I Andreasson, Maya V Yutsis und 4 weitere

Brain Communications · 24.12.2024 · 7 (1)

DOI: 10.1093/braincomms/fcae458 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Communications, online erschienen am 19.12.2024. Verfasst von Joseph R Winer und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94304, USA. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Co-pathology is frequent in Lewy body disease, which includes clinical diagnoses of both Parkinson’s disease and dementia with Lewy bodies. Measuring concomitant pathology in vivo can improve clinical and research diagnoses and prediction of cognitive trajectories. Tau PET imaging may serve a dual role in Lewy body disease by measuring cortical tau aggregation as well as assessing dopaminergic loss attributed to binding to neuromelanin within substantia nigra. We sought to characterize 18F-PI-2620, a next generation PET tracer, in individuals with Lewy body disease. We recruited 141 participants for 18F-PI-2620 PET scans from the Stanford Alzheimer’s Disease Research Center and the Stanford Aging and Memory Study, most of whom also had β-amyloid status available (139/141) from PET or cerebrospinal fluid. We compared 18F-PI-2620 uptake within entorhinal cortex, inferior temporal cortex, precuneus and lingual gyrus, as well as substantia nigra, across participants with Lewy body disease [Parkinson’s disease (n = 29), dementia with Lewy bodies (n = 14)] and Alzheimer’s disease (n = 28), in addition to cognitively unimpaired healthy older adults (n = 70). Mean bilateral signal was extracted from cortical regions of interest in 18F-PI-2620 standard uptake value ratio (inferior cerebellar grey reference) images normalized to template space. A subset of participants received cognitive testing and/or the Movement Disorders Society Unified Parkinson’s Disease Rating Scale Part III motor exam (off medication). 18F-PI-2620 uptake was low overall in Lewy body disease and correlated with β-amyloid PET in temporal lobe regions and precuneus. Moreover, inferior temporal 18F-PI-2620 uptake was significantly elevated in β-amyloid positive relative to β-amyloid negative participants with Lewy body disease. Temporal lobe 18F-PI-2620 signal was not associated with memory in Lewy body disease, but uptake within precuneus and lingual gyrus was associated with worse executive function and attention/working memory performance. Finally, substantia nigra 18F-PI-2620 signal was significantly reduced in participants with Parkinson’s disease, and lower substantia nigra signal was associated with greater motor impairment. These findings suggest that although levels are lower than in Alzheimer’s disease, small elevations in cortical tau are associated with cognitive function in Lewy body disease relevant domains, and that reduced 18F-PI-2620 binding in substantia nigra may represent loss of dopaminergic neurons. Cortical tau and neuromelanin binding within substantia nigra represent two unique signals in the same PET image that may be informative in the context of cognitive and motor deficits, respectively, in Lewy body disease.

Schlagwörter

Stichwörter der Autor:innen

Lewy body diseasemixed pathologytau PET imaging

Autor:innen und Institutionen

  • Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94304, USA.
  • Department of Radiology, Stanford University School of Medicine, Stanford, CA 94304, USA.
  • Department of Epidemiology and Population Health, Stanford University, Stanford, CA 94304, USA.
  • Wu Tsai Neuroscience Institute, Stanford University, Stanford, CA 94304, USA.

ORCID-Profile: Joseph R Winer, Edward N Wilson

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • National Institute on Aging
  • Stanford Precision Health & Integrated Diagnostics Center
  • Wu Tsai Neuroscience Institute
  • Good Planet Foundation

Zitieren

APA

Winer, J. R., Vossler, H., Young, C. B., Smith, V., Romero, A., Shahid-Besanti, M., Abdelnour, C., Wilson, E. N., Anders, D., Pacheco Morales, A., Andreasson, K. I., Yutsis, M. V., Henderson, V. W., Davidzon, G. A., Mormino, E. C., & Poston, K. L. (2024). 18F-PI-2620 Tau PET is associated with cognitive and motor impairment in Lewy body disease. Brain Communications, 7(1). https://doi.org/10.1093/braincomms/fcae458

Vancouver

Winer JR, Vossler H, Young CB, Smith V, Romero A, Shahid-Besanti M, et al. 18F-PI-2620 Tau PET is associated with cognitive and motor impairment in Lewy body disease. Brain Communications. 2024;7(1). doi:10.1093/braincomms/fcae458

BibTeX
@article{Winer2024,
  author = {Winer, Joseph R and Vossler, Hillary and Young, Christina B and Smith, Viktorija and Romero, America and Shahid-Besanti, Marian and Abdelnour, Carla and Wilson, Edward N and Anders, David and Pacheco Morales, Aimara and Andreasson, Katrin I and Yutsis, Maya V and Henderson, Victor W and Davidzon, Guido A and Mormino, Elizabeth C and Poston, Kathleen L},
  title = {18F-PI-2620 Tau PET is associated with cognitive and motor impairment in Lewy body disease},
  journal = {Brain Communications},
  year = {2024},
  volume = {7},
  number = {1},
  doi = {10.1093/braincomms/fcae458}
}
Kostenlos starten →